SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-20-000807
Filing Date
2020-08-06
Accepted
2020-08-06 16:08:15
Documents
40
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e2054.htm   iXBRL 10-Q 598068
2 EXHIBIT 31.1 e2054ex_311.htm EX-31.1 7251
3 EXHIBIT 31.2 e2054ex_312.htm EX-31.2 7925
4 EXHIBIT 32.1 e2054ex_321.htm EX-32.1 6655
5 GRAPHIC image_001.jpg GRAPHIC 47606
6 GRAPHIC image_002.jpg GRAPHIC 42715
  Complete submission text file 0001731122-20-000807.txt   2675593

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20200630.xsd EX-101.SCH 22413
8 XBRL CALCULATION FILE avxl-20200630_cal.xml EX-101.CAL 25192
9 XBRL DEFINITION FILE avxl-20200630_def.xml EX-101.DEF 68870
10 XBRL LABEL FILE avxl-20200630_lab.xml EX-101.LAB 183144
11 XBRL PRESENTATION FILE avxl-20200630_pre.xml EX-101.PRE 134620
12 EXTRACTED XBRL INSTANCE DOCUMENT e2054_htm.xml XML 309646
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 201081634
SIC: 8731 Services-Commercial Physical & Biological Research